Thromboinflammation in COVID-19: Can α₂ -macroglobulin help to control the fire?

Area of Science:

• Immunology
• Hematology
• Molecular Biology

Background:

• COVID-19 is associated with complex coagulopathy, impacting patient prognosis.
• Neutrophil extracellular traps (NETs) contribute to coagulation activation and inflammation.
• Alpha2-macroglobulin (α2-M) is a broad-spectrum protease inhibitor with potential anti-inflammatory roles.

Purpose of the Study:

• To investigate the protective role of alpha2-macroglobulin (α2-M) in COVID-19, particularly in children.
• To explore the interaction between α2-M, neutrophil activity, and COVID-19-associated coagulopathy.

Main Methods:

• Review of existing literature on COVID-19 coagulopathy, neutrophil function, and α2-M.
• Hypothesis generation based on preliminary findings and known biological mechanisms.

Main Results:

• Children may exhibit a degree of protection against severe COVID-19 due to higher α2-M levels.
• α2-M's broad protease-binding capacity may counteract neutrophil elastase and other inflammatory mediators.
• α2-M may influence coagulation pathways activated by NETs and thrombin.

Conclusions:

• Alpha2-macroglobulin (α2-M) warrants further investigation for its potential therapeutic role in managing COVID-19, especially in pediatric cases.
• Understanding α2-M's interaction with neutrophil extracellular traps and coagulation is crucial for developing novel treatment strategies.